E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/27/2004 in the Prospect News Convertibles Daily.

Medarex to call 4.5% convertible subordinated notes

Pittsburgh, May 27 - Medarex Inc. will redeem all of its outstanding 4.5% convertible subordinated notes due 2005 at a price of 101.8% of par plus accrued and unpaid interest on June 30.

The par amount of notes remaining to be redeemed is $76.3 million.

Up to the close of business, holders can convert their notes to stock at a conversion price of $28.84 per share. Medarex stock closed at $8.54 Thursday.

Medarex is a Princeton, N.J.-based biopharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.